Intermediate-Risk Childhood Acute Lymphoblastic Leukemias: Amsacrine + Cytosine Arabinoside Versus Intermediate-Dose Methotrexate for Consolidation, and 6-Mercaptopurine + Methotrexate + Vincristine Versus Monthly Pulses for Maintenance
- 1 January 1987
- book chapter
- Published by Springer Nature
- Vol. 30, 461-465
- https://doi.org/10.1007/978-3-642-71213-5_81